Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The systemic vasculitides are uncommon but serious diseases. Early recognition can be difficult because they mimic many conditions. Aggressive immunosuppression is toxic but effective; a targeted approach with biological agents may improve the outcome.

Original publication

DOI

10.12968/hmed.2014.75.8.432

Type

Journal article

Journal

British journal of hospital medicine (London, England : 2005)

Publication Date

08/2014

Volume

75

Pages

432 - 439

Addresses

Professor of Rheumatology and Consultant Rheumatologist in the National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Nuffield Orthopaedic Centre, Oxford OX3 7LD.

Keywords

Humans, Vasculitis, Anti-Inflammatory Agents, Immunologic Factors, Diagnosis, Differential, Prognosis